FDA Approval Insights: Elranatamab in Relapsed/Refractory Multiple Myeloma
Season 9, Episode 28, Sep 21, 2023, 06:00 PM
Dr Nooka discusses the FDA approval of elranatamab in relapsed/refractory multiple myeloma, key data from MagnetisMM-3, and the evolving role of bispecific antibodies in the multiple myeloma treatment paradigm.